JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Treprostinil sodium (trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation), a synthetic analog of prostacyclin (PGI2), is a novel and potent DP1 and EP2 agonist with EC50 values of 0.6+/-0.1 and 6.2+/-1.2 nM, respectively. Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.
References: Biochem Pharmacol. 2012 Jul 1; 84(1):68-75.; Expert Opin Pharmacother. 2011 Nov; 12(16):2583-93.
Related CAS#: 81846-19-7 (free acid); 830354-48-8 (diolamine)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!